U.S. Open Championship Preview and Other Key News Updates As the U.S. Open tennis tournament approaches this weekend, world-renowned athletes Aryna Sabalenka and Jannik Sinner are set to defend their

GLP-1 receptor agonists have been used to treat type 2 diabetes since 2005 and gained approval for weight management in 2014.1 However, a high between-individual heterogeneity should be acknowledged regarding

Once-weekly ecnoglutide 0·6 mg and 1·2 mg were non-inferior to dulaglutide 1·5 mg in reducing HbA1c in adults with type 2 diabetes and elevated glucose concentrations on metformin monotherapy. Although

A NEW drug developed to combat diabetes and obesity melts fat at double the rate of other GLP-1 drugs, scientists say. The injection is also quicker and cheaper to produce

Serena Williams made headlines this week, not for her tennis court achievements, but for her health challenges since giving birth to her two children. She revealed she lost about 30

Serena Williams made headlines this week, not for her tennis court achievements, but for her health challenges since giving birth to her two children. She revealed she lost about 30

The US Open starts on Sunday, and tennis GOAT Serena Williams is making headlines, but not for her sport. She told PEOPLE magazine that she used a GLP-1 drug to

The Signos system can be used alone, in combination with, or after GLP-1 drugs or bariatric surgery. Photography courtesy of Signos The FDA cleared the first glucose monitoring system specifically

Medications like Ozempic mimic the GLP-1 hormone, so the user feels fuller for longer and doesn’t crave food as often.

These are the stories making headlines in fashion on Friday. Serena Williams stars in a new campaign for Ro, a direct-to-consumer healthcare company that digitally prescribes various medications to qualifying

Serena Williams has been making headlines lately for her significant weight loss transformation. And now we know exactly how she’s been able to drop all those pounds. As we previously

Serena Williams disclosed she dropped 31 pounds with the use of GLP-1 androgen receptor weight-loss drugs. That alone wasn’t shocking since the medication, traditionally used to treat diabetes, has gained

A study has found that adults with obesity taking GLP-1 receptor agonists may face significantly lower risk of developing certain cancers.  The cohort study was led by researchers from the

By KATHERINE ROTH NEW YORK (AP) — Summer can be a time of big transitions for kids. It’s often the season for moving to a new home or preparing for

By Julie Appleby, KFF Health News Medicare enrollees who buy the optional Part D drug benefit may see substantial premium price hikes — potentially up to $50 a month —

Post Content

Key Points in This Article: Novo Nordisk (NVO) pioneered GLP-1 drugs with Ozempic and Wegovy, but lost ground to Eli Lilly’s Mounjaro and Zepbound. GLP-1 shortages allowed compounders to offer

In an exclusive story for People, Serena Williams ‘opened up’ about how she lost 31 pounds by using weight loss medication. She discussed using GLP-1 to aid her journey after

From Compton outsider to American nonpareil, she came to embody resistance to toxic norms. But her embrace of GLP-1 drugs feels like capitulation to ideals she once rejected When Serena

The mother-of-two was seen in a snakeskin print push-up bra dress by L’Agence as she stopped by the Today show to talk her weight loss.

Eli Lilly and Company LLY is a key player in the diabetes and obesity drug market, mainly due to the significant popularity and success of its GLP-1 therapies — Mounjaro

After years of struggling with postpartum weight gain despite strict training and healthy eating, the 23-time Grand Slam champion turned to a GLP-1 medication.

HAVING a beer belly can age your heart faster, a study suggests. Visceral fat that’s hidden deep in the body and surrounds the stomach, intestines and liver can drive up

Investors are souring on the obesity drug field, which was once heralded as the biggest pharmaceutical market of all time. Even as Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy continue

One query I get often is “What class/skill would you suggest our kids take/learn to compete in the modern economy?” A few years ago, people expected me to say STEM,

With the price of weight-loss injection Mounjaro rising by 170 per cent next month, we asked a pharmacist and medical nutritionist what the best affordable GLP-1 supplements are.

Health Rounds: GLP-1 drugs linked to lower cancer risks (www.reuters.com) 19:18  

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.

A MUM thought her weight loss jabs were giving her trapped wind until she was racked by pains “worse than labour”, forcing her eight-year-old daughter to call her an ambulance.

GLP-1 medications have taken America by storm, moving beyond clinical tools and becoming status symbols. Once accessible to only the wealthy and well-connected, they are now prescribed in clinics across

Patients with type 2 diabetes and atopic dermatitis show higher risk for cardiovascular events, but GLP-1 agonists reduce the risk, a new study finds. Medscape Medical News

SIERRA Robichaud was among the first wave of people to see her excess fat melt away after starting weight loss jabs – and she was stunned by how quickly they

With the price of weight-loss injection Mounjaro rising by 170 per cent next month, we asked a pharmacist and medical nutritionist what the best affordable GLP-1 supplements are.

Serena Williams is unrecognizable in swimsuit after 31-lb weight loss originally appeared on The Sporting News Tennis great Serena Williams has taken to social media to show off her dramatic

Serena Williams turned to a weight loss medication and it is paying off massively as the American tennis icon reveals she shed 31 pounds (14 kilograms).  During a conversation with

Serena Williams reveals she has been using GLP-1 medications for weight loss, shedding 31 pounds. The tennis star highlights its benefits on her health.

Fat jabbers all over the country are in meltdown following the news that Mounjaro, the most popular and effective of all the GLP-1 weight loss drugs, is set to soar

submitted by /u/PaperHandsTheDip [link] [comments]

Serena Williams openly discussed her weight loss journey after the birth of her daughters, driven by a desire to improve her health and well-being. She revealed using a GLP-1 medication,

The Olympian revealed that she has lost more than 30 pounds with the help of a GLP-1 prescription.

The tennis legend says she lost 14kg using GLP-1, but notes, “you should love yourself at any size and any look”.

Fat jabbers all over the country are in meltdown following the news that Mounjaro, the most popular and effective of all the GLP-1 weight loss drugs, is set to soar

As a tennis fan and a Serena Williams fan, I kept paying attention to Serena’s life and times after she retired in September 2022. She spoke, at the time, about

Speaking on NBC’S Today show, tennis superstar Serena Williams talks about her challenges with weight loss after having two children and her decision to use a GLP-1. NBC News’ Anne

Serena Williams has been taking a GLP-1 medication to help with her recent weight loss, she revealed for the first time in an exclusive TODAY interview. https://t.co/S1j9SQAUyQ — TODAY (@TODAYshow)

Photo: Stefanie Keenan/Getty Images for Vogue Three years after announcing her retirement from tennis, Serena Williams has a new job: advertising weight-loss medication. In an interview with Vogue, she revealed

This study provides the first clinical evidence that antisense-mediated inhibition of DGAT2 with ION224 could be a safe and efficacious strategy for the treatment of MASH. The observed histological improvements

New Developments in U.S. Legal and Environmental News A New York appellate court recently dismissed a significant $527 million penalty imposed in a civil fraud case involving former President Donald

The matcha PR arc is nothing short of iconic. Once an unknown health drink, the powdered green tea quickly replaced the flat white as the wellness girlie’s beverage of choice.

Tennis great Serena Williams has opened up about her incredible weight-loss journey, revealing that she lost 31 pounds with the help of a GLP-1 medication.  The 23-time Grand Slam champion revealed in

Telehealth company Ro’s latest campaign is focused on the tennis champion’s own weight loss using a monthly GLP-1 injection, making her the drug’s highest-profile spokesperson to date.

SERENA Williams has revealed she used fat jabs to shed pounds after giving birth to her two daughters. The tennis star has spoken for the first time about her weight

Serena Williams is opening up about her health journey, revealing she’s lost over 30 pounds with the help of a GLP-1 prescription. The tennis legend shared that after years of

Here’s the Scoop: #SerenaWilliams shares she is now using a #GLP1 in partnership with Ro, a digital health care company. Find out why she’s not worried about the public’s reaction

In the past year or couple of years, you’ve likely heard a lot about Ozempic, most likely in the context of weight loss. Not for nothing — a lot of

An extended interview cut of NBC News’ “Here’s the Scoop”: Today on the pod- The GOAT. That’s right, tennis great Serena Williams joins host Yasmin Vossoughian and reveals that she’s

The use of GLP-1 agonists is associated with a reduced overall risk of cancer. This is the conclusion of a study published Wednesday in the scientific journal Jama Oncology. The

The tennis legend has struggled with her weight for years

Please enjoy this transcript of my interview with Dr. Jeffrey Goldberg, chair of the Department of Ophthalmology and director of the Byers Eye Institute at Stanford University. He is a

To the Editor Cai et al concluded that there was a risk associated with semaglutide and nonarteritic anterior ischemic optic neuropathy (NAION) based on an analysis of the Observational Health

To the Editor Cai et al recently provided evidence about whether the glucagonlike peptide-1 receptor agonist (GLP-1RA) semaglutide is associated with nonarteritic anterior ischemic optic neuropathy (NAION). This is one

Serena Williams disclosed that she has been taking a GLP-1 medication to help with her recent weight loss. The 23-time Grand Slam champion revealed this for the first time in an

This retrospective cohort study examines whether taking glucagon-like peptide-1 receptor agonists is associated with increased risk of different cancers among patients with obesity.

The 23-time Grand Slam champion admitted to using a GLP-1 medication

New blood pressure guidelines from the AHA recommend starting treatment earlier and abstaining from alcohol. Maskot/Getty Images New blood pressure guidelines from the American Heart Association (AHA) reaffirm earlier recommendations

Away, skinny crone!

(MedPage Today) — Patients taking GLP-1 agonists for weight loss had a small but significantly lower risk of developing cancer, a large retrospective cohort study showed. With follow-up ranging from

Williams said she wanted to tell folks of her weight-loss journey to help push back against the stigma that using a GLP-1 is lazy or provides a shortcut.

On this week’s episode of “The Readout LOUD”: vikings. No, not the seafaring Norse people of the 10th century, or the Minnesota football team. The gang will discuss obesity drug

IJMS, Vol. 26, Pages 8096: Targeting Sarcopenia in CKD: The Emerging Role of GLP-1 Receptor Agonists International Journal of Molecular Sciences doi: 10.3390/ijms26168096 Authors: Vicente Llinares-Arvelo Carlos E. Martínez-Alberto Ainhoa

Tennis superstar Serena Williams joins TODAY and clears the air to announce she is taking a GLP-1 medication through Ro, for which she is a paid spokesperson. She opens up

Serena Williams opens up about GLP-1 use as a celebrity ambassador for Ro.

Serena Williams Opens Up About GLP-1 Weight Loss in New Ro Ad (www.bloomberg.com) 21:00  

After years of GLP-1 ads spotlighting anonymous bellies and dancing commercial actors, telehealth firm Ro is ushering in weight-loss drugs’ celebrity-endorsement era Serena Williams used GLP-1s to lose weight after

Serena Williams is confirming that she’s among the many people who have used a GLP-1 medication for weight loss. GLP-1 medications are commonly used to treat type 2 diabetes and

A bundled, AI-enabled health coaching program significantly improved outcomes in adults with Type 2 diabetes, a recent Cleveland Clinic study found. The intervention, developed by Twin Health, used wearable devices

Serena Williams just revealed she’s taking a popular weight loss drug, Zepbound, a GLP-1 medication, admitting she first tried to do it naturally … but nothing worked! The tennis legend

Serena Williams is serving up an honest look into her weight loss.  The tennis star—who shares daughters Alexis, 6, and Adira, 2, with husband Alexis Ohanian—recently shared how a GLP-1

WEIGHT loss jabs could lower the risk of cancer, scientists say. They found GLP-1s like Ozempic and Mounjaro reduced the overall chances of the disease by 17 per cent in

MILLIONS of people have lost staggering amounts of weight on fat jabs. But one of the downsides of GLP-1 injections commonly experienced by users is “Mounjaro butt” – where previously

Tackling the root cause of obesity. This episode features audio from: https://nutritionfacts.org/video/obesity-is-a-glp-1-deficiency-its-cause-and-how-to-treat-it-without-ozempic-and-other-drugs/ Visit the video page for all sources and doctor’s notes related to this podcast. https://NutritionFacts.org • Subscribe: https://nutritionfacts.org/subscribe

The 23-time Grand Slam winner opens up about her decision to go on the weight management drug.

FOR millions around the world, fat jabs like Mounjaro and Wegovy have been a godsend for a simple and stress-free way to shed those stubborn pounds. But if you want

After years of GLP-1 ads spotlighting anonymous bellies and dancing commercial actors, telehealth firm Ro is ushering in weight-loss drugs’ celebrity-endorsement era.

Do corporate venture arms bring credibility and customers—or conflicts and constraints? And what role do they play in an investment landscape that looks markedly different than it did a few

THROWING up for the third time in just 10 minutes, Aisleyne Horgan-Wallace thought she was dying. Unable to lift her head from her pillow, the reality star had spent three

GLP-1 receptor agonists may outperform metformin in lowering the risk for dementia, particularly Alzheimer’s disease and other nonvascular types, in patients with type 2 diabetes. Medscape Medical News

Abstract Aims The use of incretin analogues has emerged as an effective approach to achieve both enhanced insulin secretion and weight loss in Type 2 diabetes (T2D) patients. Agonists which

A WOMAN has shared her three go-to recipe which help her stay slim without resorting to Ozempic. Gina Drewalowski, who is on a mission to “spread positivity” and reveal that ageing is

Oral semaglutide treatment shows a modest reduction in serum urate levels in patients with type 2 diabetes, especially in those with elevated serum urate levels at baseline. Medscape Medical News

Inspired by the success of human weight-loss drugs, scientists are exploring similar solutions for obese dogs. Vivani Medical and Okava are testing “Ozempup,” a GLP-1 implant designed to release medication

We read with great interest the recent meta-analysis examining the comparative efficacy of GLP-1 receptor agonists (GLP-1RAs) on cardiovascular outcomes across Asian and White populations (1). While the findings are

Wonderfeel. Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. From creatine gummies to natural GLP-1 alternatives, the supplement industry is definitely

Dr. Jeffrey Goldberg is Professor and Chair of Ophthalmology and Director of the Byers Eye Institute at Stanford University, a leading scientist in the development and degeneration of the visual

Novo Nordisk, the Denmark-based pharmaceutical company that makes Ozempic and Wegovy, looks like it’s being toppled off its GLP-1 throne. In a statement to Reuters, the Danish conglomerate admitted that

Publication date: Available online 19 August 2025 Source: Journal of Controlled Release Author(s): Prosper Emeh, Maria Englund, Said Harun, Zulma Santisteban Valencia, Jeffersson Revell, Andreas Hugerth, Nigel Davies, Christel A.S.